The Saccharomyces cerevisiae phosphatase activator RRD1 is required to modulate gene expression in response to rapamycin exposure

Genetics. 2006 Feb;172(2):1369-72. doi: 10.1534/genetics.105.046110. Epub 2005 Dec 1.

Abstract

We show that mutants lacking either the phosphatase activator Rrd1 or the phosphatase Pph3 are resistant to rapamycin and that double mutants exhibit a synergistic response. This phenotype could be related to an inability of the mutants to degrade RNA polymerase II, leading to transcription of critical genes that sustain growth.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antifungal Agents / pharmacology*
  • Blotting, Northern
  • Gene Expression Regulation, Fungal / drug effects
  • Gene Expression Regulation, Fungal / physiology*
  • Intracellular Signaling Peptides and Proteins
  • Mutation
  • Peptidylprolyl Isomerase
  • Phosphoprotein Phosphatases / genetics
  • Phosphoprotein Phosphatases / physiology
  • Saccharomyces cerevisiae / drug effects
  • Saccharomyces cerevisiae / genetics*
  • Saccharomyces cerevisiae Proteins / genetics
  • Saccharomyces cerevisiae Proteins / physiology*
  • Sirolimus / pharmacology*

Substances

  • Antifungal Agents
  • Intracellular Signaling Peptides and Proteins
  • Saccharomyces cerevisiae Proteins
  • PPH3 protein, S cerevisiae
  • Phosphoprotein Phosphatases
  • Peptidylprolyl Isomerase
  • RRD1 protein, S cerevisiae
  • Sirolimus